• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Malaysia·Healthcare·5225.KL
Share

IHH Healthcare Berhad Stocks

MYR 8.73Last Updated 24.06.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

MYR 18.81B

MYR 8.73
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

IHH Healthcare Berhad, established in 2010 and headquartered in Kuala Lumpur, Malaysia, operates as an investment holding conglomerate delivering an extensive spectrum of healthcare services. Its operational footprint spans across Malaysia, Singapore, Turkey, India, China, Japan, Europe, and other international markets. The company provides a full continuum of medical care, beginning with fundamental primary services like treatment for common illnesses, outpatient consultations, health screenings, immunizations, and preventive health education. This progresses to intermediate secondary care, featuring specialist consultations, minor surgical procedures, emergency interventions, comprehensive laboratory and diagnostic services, and acute medical treatment. More advanced tertiary care encompasses highly specialized consultations, cutting-edge therapies, intricate surgical operations, and extensive inpatient management. The most complex quaternary care includes critical procedures such as organ transplantation, neurosurgery, advanced cardiac surgery, and reconstructive plastic surgery. Beyond direct patient care, IHH Healthcare offers vital support services including advanced diagnostics, analytical laboratory testing, therapeutic radiology, physiotherapy, integrated rehabilitation, and molecular diagnostics. The group also engages in medical education programs for nurses, physicians, and allied healthcare professionals, alongside administrative, management, and advisory services. Its specialized care offerings extend to emergency, home-based, orthopedic, and ambulatory services. Further diversifying its portfolio, the company provides healthcare information systems, web-based applications, and various technological solutions. It also handles services related to real estate investment trusts, manages dialysis and treasury centers, and operates a network of educational institutions, colleges, and research-focused learning centers. Its infrastructure arm is responsible for the development, construction, oversight, management, and leasing of medical and healthcare facilities. Complementary services include catering, laundry, and cleaning for hospitals, as well as the import and wholesale of pharmaceutical and medical supplies. Additionally, IHH Healthcare is involved in property leasing and provides software system integration and application management services.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, overpriced on

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 5225.KL is 11 and suggests 24.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.06.2026 15:25

Three small-cap companies in the AI sector: They could benefit from OpenAI's IPO

24.06.2026 15:11

A Morning in New York: High Tech in a Period of Turbulence

24.06.2026 14:57

Shares of biotech company Boundless soared 90% amid a market sell-off. What's the reason?

24.06.2026 14:15

Nasdaq 100 companies lost $1.3 trillion in market capitalization in two days

24.06.2026 13:44

Brent crude oil prices fell below $76—a four-month low

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026